Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.1350
-0.0650 (-32.50%)
Jul 29, 2025, 4:00 PM EDT
Biora Therapeutics Revenue
Biora Therapeutics had revenue of $32.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $892.00K, up 4,855.56% year-over-year. In the year 2023, Biora Therapeutics had annual revenue of $4.00K, down -98.69%.
Revenue (ttm)
892.00K
Revenue Growth
+4,855.56%
P/S Ratio
0.67
Revenue / Employee
15.38K
Employees
58
Market Cap
597.11K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.00K | -301.00K | -98.69% |
| Dec 31, 2022 | 305.00K | -942.00K | -75.54% |
| Dec 31, 2021 | 1.25M | 1.09M | 669.75% |
| Dec 31, 2020 | 162.00K | -143.82M | -99.89% |
| Dec 31, 2019 | 143.99M | 16.01M | 12.51% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Federal National Mortgage Association | 30.44B |
| Federal Home Loan Mortgage | 23.43B |
| Alpine Auto Brokers | 129.78K |
| First National of Nebraska | 1.89B |
| Jingbo Technology | 2.29M |
| Mechanics Bank | 381.61M |
| Procaps Group | 414.10M |
| Endo, Inc. | 1.73B |
Biora Therapeutics News
- 9 months ago - Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 9 months ago - Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 9 months ago - Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - GlobeNewsWire
- 1 year ago - Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Biora Therapeutics Announces Funding Agreement with Existing Investors - GlobeNewsWire